Lamb Peter 4
4 · EXELIXIS, INC. · Filed Dec 16, 2022
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Lamb Peter
EVP, Discovery Research & CSO
Transactions
- Exercise/Conversion
Common Stock
2022-12-15$4.20/sh+20,000$84,000→ 430,958 total - Sale
Common Stock
2022-12-15$15.88/sh−20,000$317,600→ 410,958 total - Exercise/Conversion
Option (right to buy)
2022-12-15−20,000→ 20,000 totalExercise: $4.20From: 2017-02-11Exp: 2023-02-10→ Common Stock (20,000 underlying)
Holdings
- 17,105(indirect: By 401(k))
Common Stock
Footnotes (5)
- [F1]Includes 120,383 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2022.
- [F3]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.71 to $16.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
- [F4]Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of December 14, 2022.
- [F5]The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020.